Legal & General Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.22B | Buy |
43,505,563
+641,338
| +1% | +$17.1M | 0.28% | 64 |
|
|
2025
Q4 | $1.07B | Buy |
42,864,225
+1,123,039
| +3% | +$28.3M | 0.24% | 73 |
|
|
2025
Q3 | $1.06B | Buy |
41,741,186
+3,296,415
| +9% | +$81.4M | 0.24% | 75 |
|
|
2025
Q2 | $932M | Buy |
38,444,771
+1,384,227
| +4% | +$32.3M | 0.23% | 74 |
|
|
2025
Q1 | $939M | Buy |
37,060,544
+153,979
| +0.4% | +$4.03M | 0.26% | 72 |
|
|
2024
Q4 | $979M | Sell |
36,906,565
-955,377
| -3% | -$25.9M | 0.26% | 62 |
|
|
2024
Q3 | $1.1B | Buy |
37,861,942
+702,070
| +2% | +$20.5M | 0.29% | 53 |
|
|
2024
Q2 | $1.04B | Sell |
37,159,872
-3,859,034
| -9% | -$106M | 0.29% | 54 |
|
|
2024
Q1 | $1.14B | Sell |
41,018,906
-513,451
| -1% | -$14.2M | 0.33% | 50 |
|
|
2023
Q4 | $1.2B | Sell |
41,532,357
-979,118
| -2% | -$29.6M | 0.37% | 41 |
|
|
2023
Q3 | $1.41B | Sell |
42,511,475
-1,329,245
| -3% | -$47M | 0.49% | 30 |
|
|
2023
Q2 | $1.61B | Buy |
43,840,720
+2,093,282
| +5% | +$81.5M | 0.52% | 27 |
|
|
2023
Q1 | $1.7B | Buy |
41,747,438
+614,632
| +1% | +$26.5M | 0.61% | 24 |
|
|
2022
Q4 | $2.11B | Sell |
41,132,806
-681,703
| -2% | -$32.7M | 0.81% | 18 |
|
|
2022
Q3 | $1.83B | Sell |
41,814,509
-977,163
| -2% | -$47.5M | 0.71% | 19 |
|
|
2022
Q2 | $2.24B | Buy |
42,791,672
+1,336,403
| +3% | +$68.1M | 0.79% | 14 |
|
|
2022
Q1 | $2.15B | Buy |
41,455,269
+2,866,750
| +7% | +$149M | 0.65% | 17 |
|
|
2021
Q4 | $2.28B | Sell |
38,588,519
-291,953
| -0.8% | -$14.5M | 0.69% | 16 |
|
|
2021
Q3 | $1.67B | Buy |
38,880,472
+1,486,959
| +4% | +$65.9M | 0.54% | 23 |
|
|
2021
Q2 | $1.46B | Buy |
37,393,513
+1,434,331
| +4% | +$55.8M | 0.49% | 28 |
|
|
2021
Q1 | $1.3B | Sell |
35,959,182
-539,252
| -1% | -$19.1M | 0.49% | 32 |
|
|
2020
Q4 | $1.34B | Sell |
36,498,434
-1,922,211
| -5% | -$70.5M | 0.53% | 29 |
|
|
2020
Q3 | $1.34B | Sell |
38,420,645
-558,616
| -1% | -$19.6M | 0.6% | 24 |
|
|
2020
Q2 | $1.21B | Buy |
38,979,261
+295,599
| +0.8% | +$10M | 0.58% | 26 |
|
|
2020
Q1 | $1.2B | Buy |
38,683,662
+929,791
| +2% | +$31.7M | 0.7% | 20 |
|
|
2019
Q4 | $1.4B | Buy |
37,753,871
+926,829
| +3% | +$33M | 0.67% | 24 |
|
|
2019
Q3 | $1.26B | Buy |
36,827,042
+611,347
| +2% | +$22.2M | 0.66% | 27 |
|
|
2019
Q2 | $1.49B | Sell |
36,215,695
-437,401
| -1% | -$17.4M | 0.8% | 18 |
|
|
2019
Q1 | $1.48B | Buy |
36,653,096
+5,595,890
| +18% | +$224M | 0.84% | 17 |
|
|
2018
Q4 | $1.29B | Buy |
31,057,206
+1,889,229
| +6% | +$78.4M | 1% | 12 |
|
|
2018
Q3 | $1.22B | Buy |
29,167,977
+326,548
| +1% | +$12.6M | 0.87% | 12 |
|
|
2018
Q2 | $993M | Sell |
28,841,429
-1,929,613
| -6% | -$65.9M | 0.77% | 20 |
|
|
2018
Q1 | $1.04B | Sell |
30,771,042
-2,135,171
| -6% | -$73.4M | 0.79% | 18 |
|
|
2017
Q4 | $1.13B | Sell |
32,906,213
-655,774
| -2% | -$22.4M | 0.82% | 18 |
|
|
2017
Q3 | $1.14B | Buy |
33,561,987
+399,687
| +1% | +$12.8M | 0.85% | 17 |
|
|
2017
Q2 | $1.06B | Buy |
33,162,300
+308,652
| +0.9% | +$9.73M | 0.85% | 18 |
|
|
2017
Q1 | $1.07B | Buy |
32,853,648
+1,231,115
| +4% | +$38.8M | 0.9% | 17 |
|
|
2016
Q4 | $974M | Buy |
31,622,533
+239,768
| +0.8% | +$7.32M | 0.91% | 17 |
|
|
2016
Q3 | $1.01B | Buy |
31,382,765
+77,509
| +0.2% | +$2.59M | 1.02% | 15 |
|
|
2016
Q2 | $1.05B | Buy |
31,305,256
+332,628
| +1% | +$10.6M | 1.1% | 14 |
|
|
2016
Q1 | $871M | Buy |
30,972,628
+514,557
| +2% | +$14.7M | 0.96% | 17 |
|
|
2015
Q4 | $933M | Buy |
30,458,071
+62,021
| +0.2% | +$1.95M | 1.05% | 15 |
|
|
2015
Q3 | $906M | Buy |
30,396,050
+775,242
| +3% | +$24.9M | 1.1% | 10 |
|
|
2015
Q2 | $942M | Buy |
29,620,808
+45,952
| +0.2% | +$1.5M | 1.11% | 10 |
|
|
2015
Q1 | $976M | Sell |
29,574,856
-596,254
| -2% | -$19M | 1.17% | 8 |
|
|
2014
Q4 | $892M | Sell |
30,171,110
-779,388
| -3% | -$22.3M | 1.05% | 13 |
|
|
2014
Q3 | $868M | Sell |
30,950,498
-2,037,875
| -6% | -$57.2M | 1.04% | 13 |
|
|
2014
Q2 | $929M | Buy |
32,988,373
+248,629
| +0.8% | +$7.09M | 1.08% | 13 |
|
|
2014
Q1 | $998M | Sell |
32,739,744
-1,009,009
| -3% | -$30.1M | 1.21% | 11 |
|
|
2013
Q4 | $981M | Sell |
33,748,753
-349,473
| -1% | -$10.2M | 1.19% | 11 |
|
|
2013
Q3 | $929M | Sell |
34,098,226
-2,007,576
| -6% | -$54.6M | 1.22% | 11 |
|
|
2013
Q2 | $960M | Buy |
+36,105,802
| New | +$998M | 1.33% | 10 |
|
Other funds holding PFE
VCM
VPM
Legal & General Group's PFE Position: Q1 2026 in Review
Legal & General Group increased its Pfizer (PFE) stake by 1.5% in Q1 2026, buying an estimated $17.1M and bringing the position to 43,505,563 shares worth $1.22B. The position accounts for 0.28% of the portfolio, ranked #64.
Legal & General Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.28B in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Legal & General Group held 43,505,563 shares of Pfizer worth $1.22B as of Q1 2026.
- Legal & General Group bought 641,338 Pfizer shares in Q1 2026, an estimated $17.1M.
- Pfizer made up 0.28% of Legal & General Group's portfolio in Q1 2026, its #64 holding.
- Legal & General Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's Pfizer position peaked at $2.28B in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.